Marijuana Use During Stages of Pregnancy in the United States

Letters16 May 2017Marijuana Use During Stages of Pregnancy in the United StatesNora D. Volkow, MD, Beth Han, MD, PhD, MPH, Wilson M. Compton, MD, MPE, and Carlos Blanco, MD, PhDNora D. Volkow, MDFrom National Institute on Drug Abuse, Bethesda, Maryland; Substance Abuse and Mental Health Services Administration, Rockville, Maryland; National Institute on Drug Abuse, Bethesda, Maryland., Beth Han, MD, PhD, MPHFrom National Institute on Drug Abuse, Bethesda, Maryland; Substance Abuse and Mental Health Services Administration, Rockville, Maryland; National Institute on Drug Abuse, Bethesda, Maryland., Wilson M. Compton, MD, MPEFrom National Institute on Drug Abuse, Bethesda, Maryland; Substance Abuse and Mental Health Services Administration, Rockville, Maryland; National Institute on Drug Abuse, Bethesda, Maryland., and Carlos Blanco, MD, PhDFrom National Institute on Drug Abuse, Bethesda, Maryland; Substance Abuse and Mental Health Services Administration, Rockville, Maryland; National Institute on Drug Abuse, Bethesda, Maryland.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L17-0067 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Marijuana is the most common illicit drug used during pregnancy (1). Because of concerns about potential deleterious effects on neurodevelopment, the American College of Obstetricians and Gynecologists recommends that pregnant women discontinue marijuana consumption. Despite these recommendations, use increased among pregnant and nonpregnant women between 2002 and 2014 (2). Marijuana may have different effects across pregnancy trimesters, and use may be more frequent among pregnant teenagers.Objective: To examine the prevalence of past-month marijuana use among U.S. females between 2002–2015, by pregnancy trimester and sociodemographic characteristics, across the full range of reproductive ages.Methods: Data were obtained from females ...References1. American College of Obstetricians and Gynecologists Committee on Obstetric Practice.. Committee opinion no. 637: marijuana use during pregnancy and lactation. Obstet Gynecol. 2015;126:234-8. PMID: 26241291 doi:10.1097/01.AOG.0000467192.89321.a6 CrossrefMedlineGoogle Scholar2. Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002-2014. JAMA. 2017;317:207-9. PMID: 27992619 doi:10.1001/jama.2016.17383 CrossrefMedlineGoogle Scholar3. Center for Behavioral Health Statistics and Quality. 2014 National Survey on Drug Use and Health: Methodological Resource Book Section 13: Statistical Inference Report. Rockville: Substance Abuse and Mental Health Services Administration; 2016. Accessed at www.samhsa.gov/data/sites/default/files/NSDUHmrbStatInference2014.pdf on 1 October 2016. Google Scholar4. Volkow ND, Compton WM, Wargo EM. The risks of marijuana use during pregnancy. JAMA. 2017;317:129-30. PMID: 27992628 doi:10.1001/jama.2016.18612 CrossrefMedlineGoogle Scholar5. Salas-Wright CP, Vaughn MG, Ugalde J, Todic J. Substance use and teen pregnancy in the United States: evidence from the NSDUH 2002-2012. Addict Behav. 2015;45:218-25. PMID: 25706068 doi:10.1016/j.addbeh.2015.01.039 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From National Institute on Drug Abuse, Bethesda, Maryland; Substance Abuse and Mental Health Services Administration, Rockville, Maryland; National Institute on Drug Abuse, Bethesda, Maryland.Note: Dr. Han had full access to all of the data in this study and takes responsibility for the integrity of the data and the accuracy of the data analysis.Disclaimer: The findings and conclusions of this study are those of the authors and do not necessarily reflect the views of the National Institute on Drug Abuse of the National Institutes of Health, Substance Abuse and Mental Health Services Administration, or U.S. Department of Health and Human Services. The sponsors supported the authors, who were responsible for preparation, review, and approval of the manuscript and the decision to submit the manuscript for publication. The sponsors had no role in the design and conduct of the study, analysis and interpretation of the data, preparation and review of the manuscript, or decision to submit the manuscript for publication. The sponsors reviewed and approved the manuscript. Dr. Compton reports ownership of stock in General Electric, 3M, and Pfizer unrelated to the submitted work; Dr. Blanco reports ownership of stock in General Electric, Sanofi, and Eli Lilly unrelated to the submitted work. Drs. Volkow and Han have no conflicts to disclose.Financial Support: The NSDUH was supported by contracts from the Substance Abuse and Mental Health Services Administration. This study was jointly sponsored by the National Institute on Drug Abuse of the National Institutes of Health and the Substance Abuse and Mental Health Services Administration of the U.S. Department of Health and Human Services.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L17-0067.This article was published at Annals.org on 18 April 2017. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byFactors associated with ever using cannabidiol in a cohort of younger pregnant peoplePatterns of Cannabis- and Substance-Related Congenital General Anomalies in Europe: A Geospatiotemporal and Causal Inferential StudyInfluence of prenatal cannabinoid exposure on early development and beyondPrenatal substance use in the rural and Appalachian state: Project WATCH study 2020‐2022European Epidemiological Patterns of Cannabis- and Substance-Related Congenital Neurological Anomalies: Geospatiotemporal and Causal Inferential StudyEffect of maternal adverse childhood experiences (ACE) and cannabis use on pregnancy outcomesGeotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001–2015Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: part 1 – continuous bivariate analysisPregnant Women Following Bariatric Surgery: a Focus on Maternal Mental Health and Its Impact on Birth OutcomesState Trends of Cannabis Liberalization as a Causal Driver of Increasing Testicular Cancer Rates across the USAEffects of cannabis on congenital limb anomalies in 14 European nations: A geospatiotemporal and causal inferential studyPharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and BreastfeedingImpact of converging sociocultural and substance-related trends on US autism rates: combined geospatiotemporal and causal inferential analysisReasons Washington State Women Use Marijuana During Pregnancy/Breastfeeding, Their Trusted Information Sources, and Communication Strategies for Informed Decision-Making"It's so Natural It Goes Hand in Hand": A Qualitative Study of Maternal Perceptions of Cannabis Use during PregnancyModes of cannabis administration in the year prior to conception among patients in Northern CaliforniaTrend Analysis of Substance Use Disorder During PregnancyCannabinoid and substance relationships of European congenital anomaly patterns: a space-time panel regression and causal inferential studyBehavioral consequences of pre/peri-natal Cannabis exposureEpidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer developmentPregnant people's experiences discussing their cannabis use with prenatal care providers in a state with legalized cannabisWomen's Cigarette and Marijuana Use in Pregnancy: Identifying the Role of Past Versus Recent Violence ExposureDaily Cannabis Use During Pregnancy and Postpartum in a State With Legalized Recreational CannabisMarijuana and Opioid Use during Pregnancy: Using Zebrafish to Gain Understanding of Congenital Anomalies Caused by Drug Exposure during DevelopmentCannabis use during pregnancy in the United States: The role of depressionPrenatal tobacco and marijuana co-use: Sex-specific influences on infant cortisol stress responseMonitoring Perinatal Exposure to Cannabis and Synthetic CannabinoidsFetal Alcohol Spectrum Disorders in a Midwestern City: Child Characteristics, Maternal Risk Traits, and PrevalenceOnline patient-provider cannabis consultationsToxicologyEffects of prenatal alcohol and cannabis exposure on neurodevelopmental and cognitive disabilitiesCannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog InteractionCannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological TrendsSelf-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United StatesBeliefs and attitudes regarding prenatal marijuana use: Perspectives of pregnant women who report useTrends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009–2016Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017Brief Commentary: Marijuana Use During Gestation and Lactation—Harmful Until Proved SafeEli Y. Adashi, MD, MSCannabis Use Disorder During the Perinatal PeriodPsychosocial Correlates of Marijuana Use among Pregnant and Nonpregnant Adolescent GirlsRisks and Benefits of Marijuana Use A National Survey of U.S. AdultsSalomeh Keyhani, MD, MPH, Stacey Steigerwald, MSSA, Julie Ishida, MD, MAS, Marzieh Vali, MS, Magdalena Cerdá, DrPH, Deborah Hasin, PhD, Camille Dollinger, BS, Sodahm R. Yoo, BS, and Beth E. Cohen, MD, MASAdditive drug-specific and sex-specific risks associated with co-use of marijuana and tobacco during pregnancy: Evidence from 3 recent developmental cohorts (2003–2015)Media portrayal of prenatal and postpartum marijuana use in an era of scientific uncertaintyAssociation between use of marijuana and time to pregnancy in men and women: findings from the National Survey of Family GrowthPreclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid ExposureSubstance Use Among Young Mothers: An Analysis of Facebook PostsThoughts About Journals, Altruism, Impact Factors, Marijuana, and the Physician Labeling Rule 16 May 2017Volume 166, Issue 10Page: 763-764KeywordsAddictionAdolescentsDisclosureDrug abuseDrugsHealth surveysMarijuanaPregnancyPsychiatry and mental healthSubstance abuse ePublished: 18 April 2017 Issue Published: 16 May 2017 Copyright & PermissionsCopyright © 2017 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...